| Primary |
| Prophylactic Chemotherapy |
100.0% |
|
| Infusion Site Erythema |
50.0% |
| Stevens-johnson Syndrome |
50.0% |
|
| Secondary |
| Unevaluable Event |
21.3% |
| Hypertension |
15.0% |
| Drug Use For Unknown Indication |
7.5% |
| Hyperuricaemia |
7.5% |
| Hypercholesterolaemia |
6.3% |
| Coronary Artery Disease |
5.0% |
| Gout |
5.0% |
| Wound Infection |
5.0% |
| Diabetes Mellitus |
3.8% |
| Cerebral Infarction |
2.5% |
| Diabetes Mellitus Non-insulin-dependent |
2.5% |
| Gastritis |
2.5% |
| Hepatitis C |
2.5% |
| Hyperlipidaemia |
2.5% |
| Myeloid Leukaemia |
2.5% |
| Neuralgia |
2.5% |
| Renal Failure Chronic |
2.5% |
| Anaemia |
1.3% |
| Bedridden |
1.3% |
| Essential Hypertension |
1.3% |
|
| Tongue Oedema |
14.8% |
| Thrombocytopenia |
11.1% |
| Tongue Disorder |
7.4% |
| Urticaria |
7.4% |
| Drug Specific Antibody Absent |
3.7% |
| Heart Rate Abnormal |
3.7% |
| Lichenoid Keratosis |
3.7% |
| Nausea |
3.7% |
| Pancytopenia |
3.7% |
| Protein Urine |
3.7% |
| Proteinuria |
3.7% |
| Renal Failure Acute |
3.7% |
| Respiratory Failure |
3.7% |
| Skin Lesion |
3.7% |
| Speech Disorder |
3.7% |
| Stevens-johnson Syndrome |
3.7% |
| Suicidal Ideation |
3.7% |
| Tachyarrhythmia |
3.7% |
| Tumour Lysis Syndrome |
3.7% |
| Vomiting |
3.7% |
|
| Concomitant |
| Drug Use For Unknown Indication |
24.6% |
| Hypertension |
12.5% |
| Product Used For Unknown Indication |
10.4% |
| Prophylaxis |
6.9% |
| Multiple Myeloma |
4.4% |
| Insomnia |
3.8% |
| Chronic Lymphocytic Leukaemia |
3.5% |
| Gout |
3.3% |
| Diabetes Mellitus |
3.2% |
| Hypercholesterolaemia |
3.2% |
| Hyperuricaemia |
3.2% |
| Non-small Cell Lung Cancer |
3.2% |
| Pain |
2.9% |
| Depression |
2.6% |
| Nausea |
2.4% |
| Chronic Obstructive Pulmonary Disease |
2.3% |
| Mantle Cell Lymphoma |
2.1% |
| B-cell Lymphoma |
2.0% |
| Prophylaxis Against Transplant Rejection |
2.0% |
| Chronic Hepatitis C |
1.8% |
|
| Renal Failure Acute |
16.4% |
| Renal Failure |
9.0% |
| White Blood Cell Count Decreased |
8.2% |
| Vomiting |
6.6% |
| Pyrexia |
4.9% |
| Rhabdomyolysis |
4.9% |
| Infection |
4.1% |
| Septic Shock |
4.1% |
| Syncope |
4.1% |
| Thrombocytopenia |
4.1% |
| Upper Gastrointestinal Haemorrhage |
4.1% |
| Liver Function Test Abnormal |
3.3% |
| Platelet Count Decreased |
3.3% |
| Respiratory Failure |
3.3% |
| Tachycardia |
3.3% |
| Tooth Abscess |
3.3% |
| Tremor |
3.3% |
| Urinary Tract Infection |
3.3% |
| Vasculitis |
3.3% |
| Weight Increased |
3.3% |
|
| Interacting |
|
| Prothrombin Time Prolonged |
100.0% |
|
